Cellectis Historical Cash Flow

CLLS Stock  USD 2.10  0.03  1.41%   
Analysis of Cellectis cash flow over time is an excellent tool to project Cellectis SA future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Stock Based Compensation of 5 M or Begin Period Cash Flow of 164.8 M as it is a great indicator of Cellectis ability to facilitate future growth, repay debt on time or pay out dividends.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Cellectis SA latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cellectis SA is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cellectis SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Cellectis Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Cellectis balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Cellectis's non-liquid assets can be easily converted into cash.

Cellectis Cash Flow Chart

At this time, Cellectis' Change In Cash is comparatively stable compared to the past year. Begin Period Cash Flow is likely to gain to about 164.8 M in 2024, whereas Free Cash Flow is likely to drop (27.1 M) in 2024.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Capital Expenditures

Capital Expenditures are funds used by Cellectis SA to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Cellectis operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Cellectis SA financial statement analysis. It represents the amount of money remaining after all of Cellectis SA operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Net Borrowings

The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.
Most accounts from Cellectis' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Cellectis SA current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cellectis SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
At this time, Cellectis' Change In Cash is comparatively stable compared to the past year. Begin Period Cash Flow is likely to gain to about 164.8 M in 2024, whereas Free Cash Flow is likely to drop (27.1 M) in 2024.

Cellectis cash flow statement Correlations

0.090.590.32-0.44-0.27-0.01-0.470.440.320.84-0.090.150.54-0.07-0.46-0.110.360.54
0.09-0.21-0.470.64-0.37-0.280.1-0.210.750.35-0.260.15-0.150.080.070.59-0.480.21
0.59-0.210.61-0.73-0.170.14-0.690.74-0.320.22-0.30.240.12-0.1-0.10.10.520.64
0.32-0.470.61-0.460.02-0.16-0.390.44-0.240.09-0.23-0.240.23-0.220.12-0.50.950.15
-0.440.64-0.73-0.46-0.14-0.170.59-0.630.71-0.03-0.23-0.15-0.440.160.270.08-0.4-0.52
-0.27-0.37-0.170.02-0.140.28-0.05-0.49-0.38-0.310.30.510.04-0.2-0.1-0.22-0.04-0.3
-0.01-0.280.14-0.16-0.170.28-0.14-0.34-0.23-0.35-0.020.47-0.23-0.12-0.3-0.17-0.1-0.32
-0.470.1-0.69-0.390.59-0.05-0.14-0.310.27-0.160.27-0.51-0.510.610.26-0.11-0.34-0.47
0.44-0.210.740.44-0.63-0.49-0.34-0.31-0.30.29-0.09-0.250.110.220.060.180.360.71
0.320.75-0.32-0.240.71-0.38-0.230.27-0.30.63-0.3-0.07-0.040.13-0.050.02-0.14-0.11
0.840.350.220.09-0.03-0.31-0.35-0.160.290.63-0.070.040.40.06-0.32-0.070.160.37
-0.09-0.26-0.3-0.23-0.230.3-0.020.27-0.09-0.3-0.07-0.230.210.04-0.51-0.22-0.14-0.12
0.150.150.24-0.24-0.150.510.47-0.51-0.25-0.070.04-0.230.0-0.32-0.110.33-0.340.13
0.54-0.150.120.23-0.440.04-0.23-0.510.11-0.040.40.210.0-0.51-0.34-0.180.270.35
-0.070.08-0.1-0.220.16-0.2-0.120.610.220.130.060.04-0.32-0.510.090.27-0.230.11
-0.460.07-0.10.120.27-0.1-0.30.260.06-0.05-0.32-0.51-0.11-0.340.090.25-0.08-0.06
-0.110.590.1-0.50.08-0.22-0.17-0.110.180.02-0.07-0.220.33-0.180.270.25-0.660.59
0.36-0.480.520.95-0.4-0.04-0.1-0.340.36-0.140.16-0.14-0.340.27-0.23-0.08-0.660.03
0.540.210.640.15-0.52-0.3-0.32-0.470.71-0.110.37-0.120.130.350.11-0.060.590.03
Click cells to compare fundamentals

Cellectis Account Relationship Matchups

Cellectis cash flow statement Accounts

201920202021202220232024 (projected)
Change In Cash(111.0M)(99.4M)(55.5M)(92.4M)43.5M45.7M
Stock Based Compensation26.9M10.0M11.5M6.0M5.2M5.0M
Free Cash Flow(82.1M)(126.5M)(124.3M)(89.9M)(25.8M)(27.1M)
Change In Working Capital11.7M(21.8M)(4.2M)(5.7M)(4.0M)(3.8M)
Begin Period Cash Flow451.5M340.5M241.1M185.6M93.2M164.8M
Other Cashflows From Financing Activities(3.9M)(1.3M)13.5M8.3M(9.6M)(9.2M)
Depreciation6.9M9.8M16.6M18.4M18.5M19.4M
Other Non Cash Items(8.3M)12.0M(5.6M)(7.6M)71.9M75.5M
Capital Expenditures13.0M46.3M19.7M2.4M1.1M1.0M
Total Cash From Operating Activities(69.1M)(80.3M)(104.6M)(87.4M)(24.7M)(26.0M)
Net Income(115.2M)(97.5M)(125.1M)(98.7M)(116.8M)(111.0M)
Total Cash From Financing Activities(3.9M)27.3M47.5M1.1M82.9M56.2M
End Period Cash Flow340.5M241.1M185.6M93.2M136.7M175.2M
Sale Purchase Of Stock3.1M186.7M(469K)(569K)(654.4K)(621.6K)
Change To Inventory(37K)(2.6M)1.3M1.6M1.7M0.0
Change To Account Receivables(2.7M)(8.3M)(5.8M)(3.2M)2.3M2.4M
Investments(35.9M)(54.3M)27.0M(2.8M)(15.5M)(14.7M)
Net Borrowings(3.4M)17.6M(12.5M)(6.6M)(5.9M)(5.6M)
Total Cashflows From Investing Activities(35.9M)(54.3M)7.3M(2.8M)(2.5M)(2.6M)
Change To Operating Activities7.4M(685K)654K(5.8M)(5.2M)(5.0M)
Change To Netincome14.4M12.8M(2.8M)6.0M5.4M5.1M
Change To Liabilities9.6M(14.1M)(583K)3.3M2.9M3.1M
Issuance Of Capital Stock(125K)9.2M48.5M13.2M67.9M50.0M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cellectis Stock Analysis

When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.